Annualized myopia progression demonstrated similar opposite effect between atropine and placebo groups but did not reach statistical significance.
← all excerpts
Efficacy of 0.01% atropine for myopia control in a randomized, placebo-controlled trial depends on baseline electroretinal response.
1
—
—